Evidence map›Paper›PMID 42853444›Full record

ArticleJournal of ophthalmic inflammation and infection2026

Clinical presentations, complications, and outcomes of benoxinate topical ophthalmic anesthetic abuse: a retrospective cohort study.

Suzan Ibrahim Sakr, Amira Ahmed Nayel, Dina Hazem ElHennawi, Fatma Ibrahim Saad, Alaa Atef Ghaith

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of ophthalmic inflammation and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suzan Ibrahim SakrCornea Clinic, Alexandria Ophthalmology Hospital, Ministry of Health and Population of Egypt, Alexandria, Egypt. suzansakr3@gmail.com.
Amira Ahmed NayelClinical Pharmacy Department, Alexandria Ophthalmology Hospital, Ministry of Health and Population of Egypt, Alexandria, Egypt.
Dina Hazem ElHennawiCornea Clinic, Alexandria Ophthalmology Hospital, Ministry of Health and Population of Egypt, Alexandria, Egypt.
Fatma Ibrahim SaadCornea Clinic, Alexandria Ophthalmology Hospital, Ministry of Health and Population of Egypt, Alexandria, Egypt.
Alaa Atef GhaithOphthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTopical anesthetic abuse is a concerning ophthalmic morbidity that may lead to irreversible visual loss. The primary goal of this study was to compare the clinical presentations, complications, healing duration and visual acuity changes between topical ophthalmic anesthetic users and non-users after superficial corneal trauma. The secondary goal was to correlate different variables related to the use of topical ophthalmic anesthetics with the final clinical outcomes.

methodsThis retrospective cohort study reviewed files of patients with a positive history of superficial corneal trauma at Alexandria Ophthalmology Hospital Cornea Clinic, Alexandria, Egypt, between January 2021 and January 2026. Patients were divided according to the use of benoxinate eye drops into two groups (benoxinate users and benoxinate non-users). Data extracted included the patient's job, the cause of the initial injury, the use of topical ophthalmic anesthetic (duration, frequency, and continuation after presentation), clinical picture, complications, healing duration, and visual outcomes.

resultsA total of 181 eyes in 147 patients was included, 84 eyes in benoxinate users and 97 eyes in benoxinate non-users. Welders (76.2%), and males (89.3%) predominated in the benoxinate group (p < 0.001). The mean duration of benoxinate use was 11.67 (2-50) days. Clinical manifestations, particularly corneal melting (15 eyes, 17.9%), eyelid contact dermatitis (9 eyes, 10.7%), ring infiltration (26 eyes, 31.0%), complications as corneal vascularization (7 eyes, 8.3%), and perforation (17 eyes, 20.2%) were significantly higher in benoxinate users. Mean difference in visual acuity before and after treatment was significantly lower in benoxinate users (0.18 ± 0.25) than in benoxinate non-users (0.34 ± 0.23), (p < 0.001). Mean healing duration was markedly longer in benoxinate users (41.05 (4- 100)) days compared with the benoxinate non-users (7.93 (3-21)) days (p < 0.001). Adherent leukoma was observed only in patients who continue using benoxinate after starting treatment (15 eyes, 48.4%).

conclusionsAbusing topical ophthalmic anesthetics is associated with severe, permanent, and sight-threatening outcomes. Frequent and prolonged use of topical ophthalmic anesthetics aggravates ocular complications, and delays healing.

Indexed as

Anesthetics keratopathyBenoxinate toxicityCorneal traumaRing infiltrationTopical anesthetic abuse

Identifiers

PMID42853444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.